Stocks · News reference
Abbott To Rally Over 31%? Here Are 10 Top Analyst Forecasts For Friday
Analysts raised targets for ACN, SYNA, ATRC and MPC; cut targets for CSX, NKE, MKC and FHTX, with ATRC downgraded to Hold.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Europe Point of Care Diagnostics Market Size and Forecast, 2021 - 2031 | Market to Reach US$21.4 Billion by 2031 as Rapid Testing and Molecular Innovation Drive 13.4% CAGR
Europe's Point of Care (POC) Diagnostics Market is projected to grow from US$8.9 billion in 2024 to US$21.4 billion by 2031, with a 13.4% CAGR driven by rapid testing innovation, molecular diagnostics advancement, and increasing prevalence of infectious and chronic diseases. Germany leads the regional market, supported by strong healthcare infrastructure and public health initiatives. Key players include Siemens AG, Abbott Laboratories, Roche, bioMerieux, Bio-Rad, QIAGEN, Nova Biomedical, Polymer Technology Systems, and Danaher Corp.
FDA Approves Abbott's Updated CardioMEMS HF System
AMD To Rally More Than 10%? Here Are 10 Top Analyst Forecasts For Monday
Analysts raised targets for ON, AMD and WTFC, while cutting GNRC, LAD, ALGN, PLNT and CRDO; ALGN was downgraded.
Anthropic Commits $100 Million Behind AI Talent Push, Plans to Train 10,000 Engineers by 2027 as IPO Looms
Anthropic launches a $100 million academy to train 10,000 AI engineers by 2027 as demand for AI talent surges.
Accenture Stock Pulls Back as Investors Book Profits
Accenture stock dips 5% as investors take profits following a 20% rally, while analysts weigh organic growth against a $5B M&A deployment strategy.